Philip Ferneau
CIK: 0001814202
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
CMPX
Compass Therapeutics, Inc.
Director
Discretionary Trading P&L
Holdings
About Ferneau Philip
Ferneau Philip (SEC CIK 0001814202) files insider reports with the SEC as Director of Compass Therapeutics, Inc. (CMPX).
Signal8 holds 2 ownership filings by Ferneau Philip, all Form 4s, filed between Feb 13, 2025 and Jan 5, 2026. Those filings report 2 transactions, from Feb 11, 2025 to Jan 2, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Ferneau Philip's filings is in BOSTON, MA.
Recent filings by Ferneau Philip
Other insiders filing for Compass Therapeutics, Inc. (CMPX)
- Lerner Neil, Chief Accounting Officer
- Anderman Jonathan, General Counsel
- Schuetz Thomas J., CHIEF EXECUTIVE OFFICER
- Shin Barry, CFO
- Sirard Cynthia, Chief Medical Officer
- Prasad Arjun, Chief Commercial Officer